Forty‐three key gene expressions involved in the effect of indoleamine 2, 3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2, 3‐dioxygenase 1 inhibitor biomarker. Issue 2 (17th February 2021)